Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
7,819,192
-
Total 13F shares
-
3,468,161
-
Share change
-
+1,928,948
-
Total reported value
-
$8,671,655
-
Put/Call ratio
-
363%
-
Price per share
-
$2.50
-
Number of holders
-
17
-
Value change
-
+$4,799,078
-
Number of buys
-
12
-
Number of sells
-
5
Institutional Holders of PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value (PMCB) as of Q4 2021
As of 31 Dec 2021,
PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value (PMCB) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,468,161 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, Shay Capital LLC, VANGUARD GROUP INC, EQUITEC PROPRIETARY MARKETS, LLC, Anson Funds Management LP, Ayrton Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, MORGAN STANLEY, and SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.